Company · CIK 0000939767 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
EXELIXIS, INC. · EXEL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 SForm 4 → | Aug 12, 7:34 pm EDT | Mary C BeckerleDirector | 9,812 | $53.66 | $526,512 | 16,079 | −37.9% | 10b5-1 |
| Jun 1, 2026 SForm 4 → | Jun 3, 6:52 pm EDT | Jack L WyszomierskiDirector | 3,925 | $50.55 | $198,409 | 284,384 | −1.36% | 10b5-1 |
| Jun 1, 2026 SForm 4 → | Jun 3, 6:51 pm EDT | Sue Gail EckhardtDirector | 9,812 | $50.14 | $491,974 | 16,079 | −37.9% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.